Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings

被引:28
作者
Breukel, AIM [1 ]
daSilva, FHL [1 ]
Ghijsen, WEJM [1 ]
机构
[1] UNIV AMSTERDAM,INST NEUROBIOL,GRAD SCH NEUROSCI,NL-1098 SM AMSTERDAM,NETHERLANDS
关键词
cholecystokinin; amino acids; exocytosis; synaptosomes; central nervous system;
D O I
10.1016/S0304-3940(97)00678-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The modulation of endogenous amino acid transmitter release by the sulphated octapeptide cholecystokinin (CCK-8S) was investigated in purified rat hippocampal synaptosomes. In the presence of extracellular Ca2+, CCK-8S increased the basal release of glutamate, but not of aspartate and GABA. In addition, CCK-8S dose-dependently increased the KCI-evoked Ca2+-dependent release of both glutamate and aspartate to about 1.4-fold at concentrations greater than or equal to 0.5 mu M. CCK-8S did not change the KCl-evoked Ca2+-dependent GABA release, not even in the presence of the GABA uptake carrier blocker N-(4,4-diphenyl-3-butenyl)-3-piperidine carboxylic acid 89976-A (SK&F89976-A; 10 mu M). The CCKB receptor antagonist L365,260 (1 mu M) blocked the CCK-8S-induced release of glutamate by 70%, and of aspartate by 100%. In conclusion, CCK stimulates exocytosis of excitatory amino acids in rat hippocampus by activating a low-affinity presynaptic CCK receptor, presumably of the B-subtype. However, CCK does not modulate the release of GABA, which has been reported to be colocalized with this peptide. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 28 条
[1]   EFFECT OF CHOLECYSTOKININ OCTAPEPTIDE ON ENDOGENOUS AMINO-ACID RELEASE FROM THE RAT VENTROMEDIAL NUCLEUS OF THE HYPOTHALAMUS AND STRIATUM [J].
BARNES, S ;
WHISTLER, HL ;
HUGHES, J ;
WOODRUFF, GN ;
HUNTER, JC .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) :1409-1416
[2]   IONIC MECHANISMS UNDERLYING CHOLECYSTOKININ ACTION IN RAT-BRAIN [J].
BODEN, P ;
WOODRUFF, GN .
CHOLECYSTOKININ, 1994, 713 :129-137
[3]   EXCITATORY EFFECTS OF CHOLECYSTOKININ IN RAT HIPPOCAMPUS - PHARMACOLOGICAL RESPONSE COMPATIBLE WITH CENTRAL-TYPE OR B-TYPE CCK RECEPTORS [J].
BOHME, GA ;
STUTZMANN, JM ;
BLANCHARD, JC .
BRAIN RESEARCH, 1988, 451 (1-2) :309-318
[4]   THE UREIDOACETAMIDES, A NOVEL FAMILY OF NONPEPTIDE CCK-B/GASTRIN ANTAGONISTS [J].
BOHME, GA ;
BERTRAND, P ;
GUYON, C ;
CAPET, M ;
PENDLEY, C ;
STUTZMANN, JM ;
DOBLE, A ;
DUBROEUCQ, MC ;
MARTIN, G ;
BLANCHARD, JC .
CHOLECYSTOKININ, 1994, 713 :118-120
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
Breukel A I, 1997, Methods Mol Biol, V72, P33
[7]   AUTORADIOGRAPHIC LOCALIZATION OF CHOLECYSTOKININ A-RECEPTOR AND B-RECEPTOR IN RAT-BRAIN USING [I-125] D-TYR25 (NLE28,31)-CCK 25-33S [J].
CARLBERG, M ;
GUNDLACH, AL ;
MERCER, LD ;
BEART, PM .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1992, 4 (06) :563-573
[8]   THE ACTIONS OF CHOLECYSTOKININ AND RELATED PEPTIDES ON PYRAMIDAL NEURONS OF THE MAMMALIAN HIPPOCAMPUS [J].
DODD, J ;
KELLY, JS .
BRAIN RESEARCH, 1981, 205 (02) :337-350
[9]   INVIVO BINDING AFFINITIES OF CHOLECYSTOKININ AGONISTS AND ANTAGONISTS DETERMINED USING THE SELECTIVE CCKB AGONIST (H-3)PBC 264 [J].
DURIEUX, C ;
RUIZGAYO, M ;
ROQUES, BP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 209 (03) :185-193
[10]   CHARACTERIZATION AND VISUALIZATION OF CHOLECYSTOKININ RECEPTORS IN RAT-BRAIN USING [PENTAGASTRIN-H-3 [J].
GAUDREAU, P ;
QUIRION, R ;
STPIERRE, S ;
PERT, CB .
PEPTIDES, 1983, 4 (05) :755-762